321 related articles for article (PubMed ID: 23123017)
21. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
[TBL] [Abstract][Full Text] [Related]
22. New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity.
Galal SA; Hegab KH; Kassab AS; Rodriguez ML; Kerwin SM; el-Khamry AM; el-Diwani HI
Eur J Med Chem; 2009 Apr; 44(4):1500-8. PubMed ID: 18752870
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
Refaat HM
Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
[TBL] [Abstract][Full Text] [Related]
24. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazone derivatives.
Wardakhan WW; El-Sayed NN; Mohareb RM
Acta Pharm; 2013 Mar; 63(1):45-57. PubMed ID: 23482312
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
27. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, in vitro and in vivo antitumor and antiviral activity of novel 1-substituted benzimidazole derivatives.
Shaker YM; Omar MA; Mahmoud K; Elhallouty SM; El-Senousy WM; Ali MM; Mahmoud AE; Abdel-Halim AH; Soliman SM; El Diwani HI
J Enzyme Inhib Med Chem; 2015; 30(5):826-45. PubMed ID: 25567722
[TBL] [Abstract][Full Text] [Related]
29. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity.
Woo HB; Eom YW; Park KS; Ham J; Ahn CM; Lee S
Bioorg Med Chem Lett; 2012 Jan; 22(2):933-6. PubMed ID: 22222040
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic and melanogenesis-inhibitory activities of limonoids from the leaves of Azadirachta indica (Neem).
Takagi M; Tachi Y; Zhang J; Shinozaki T; Ishii K; Kikuchi T; Ukiya M; Banno N; Tokuda H; Akihisa T
Chem Biodivers; 2014 Mar; 11(3):451-68. PubMed ID: 24634075
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
33. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel benzimidazole functionalized chiral thioureas and evaluation of their antibacterial and anticancer activities.
Madabhushi S; Mallu KK; Vangipuram VS; Kurva S; Poornachandra Y; Ganesh Kumar C
Bioorg Med Chem Lett; 2014 Oct; 24(20):4822-5. PubMed ID: 25241926
[TBL] [Abstract][Full Text] [Related]
35. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
Shi L; Wu TT; Wang Z; Xue JY; Xu YG
Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent.
Azam M; Khan AA; Al-Resayes SI; Islam MS; Saxena AK; Dwivedi S; Musarrat J; Trzesowska-Kruszynska A; Kruszynski R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 142():286-91. PubMed ID: 25706598
[TBL] [Abstract][Full Text] [Related]
37. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Abdelgawad MA; Bakr RB; Omar HA
Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
[TBL] [Abstract][Full Text] [Related]
39. Novel benzimidazole analogs as inhibitors of EGFR tyrosine kinase.
Yadav S; Sinha D; Singh SK; Singh VK
Chem Biol Drug Des; 2012 Oct; 80(4):625-30. PubMed ID: 22564276
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
